Michael J. Cavnar

Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido

Vinod P. Balachandran, Michael J. Cavnar, Shan Zeng et al. · Nature Medicine · 2011 · 517 citations · Full text

Cancer Immunosurveillance, Gastrointestinal Oncology, Medicine +7

KIT oncogene inhibition drives intratumoral macrophage M2 polarization

Michael J. Cavnar, Shan Zeng, Teresa S. Kim et al. · The Journal of Experimental Medicine · 2013 · 126 citations · Full text

Cancer Research, Tumor-associated Macrophages, Oncogenic Agent +14

Outcome of 1000 Patients With Gastrointestinal Stromal Tumor (GIST) Treated by Surgery in the Pre- and Post-imatinib Eras

Michael J. Cavnar, Kenneth Seier, Christina Curtin et al. · Annals of Surgery · 2019 · 92 citations · Full text

Surgical Oncology, Post-imatinib Eras, Prognosis +18

Neutrophil IL-10 suppresses peritoneal inflammatory monocytes during polymicrobial sepsis

Lee M. Ocuin, Zubin M. Bamboat, Vinod P. Balachandran et al. · Journal of Leukocyte Biology · 2010 · 87 citations · Full text

Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome

Michael J. Cavnar, Lin Wang, Vinod P. Balachandran et al. · Annals of Surgical Oncology · 2017 · 81 citations · Full text

Surgical Oncology, Gastrointestinal Oncology, Colorectal Surgery +9